Login / Signup

Cost-effectiveness evaluation of the PROPPR trial transfusion protocols.

Rachael A CallcutKit N SimpsonSarah BaraniukErin E FoxBarbara C TilleyJohn B Holcombnull null
Published in: Transfusion (2020)
The 1:1:1 transfusion ratio in severely injured hemorrhaging trauma patients is a very cost-effective strategy for increasing hemostasis and decreasing trauma deaths.
Keyphrases
  • trauma patients
  • cardiac surgery
  • sickle cell disease
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • randomized controlled trial